So L, White R, Arison B, Petuch B, Schwartz M S, Cheng H, Monaghan R, Chen T S
Merck Research Laboratories, Department of Fermentation Microbiology, Rahway, NJ 07065, USA.
J Ind Microbiol. 1995 Aug;15(2):108-11. doi: 10.1007/BF01569808.
The microbiological transformation of N-heptyl physostigmine (L-693,487) (1), a semisynthetic physostigmine cholinesterase inhibitor, was investigated using Verticillium lecanii MF 5713 (ATCC 74148), Acremonium sp MF 5723 (ATCC 74164) and Actinoplanes sp MA 6559 (ATCC 53771). Nine microbial metabolites (2-10) of 1 were isolated and purified using reversed-phase HPLC. The structures of the metabolites were established using spectroscopic techniques including MS and NMR. Some of the microbial metabolites were identical to metabolites present in urine of a dog treated with 1.
研究了半合成毒扁豆碱胆碱酯酶抑制剂N-庚基毒扁豆碱(L-693,487)(1)在蜡蚧轮枝菌MF 5713(美国典型培养物保藏中心74148)、顶孢霉属MF 5723(美国典型培养物保藏中心74164)和游动放线菌属MA 6559(美国典型培养物保藏中心53771)作用下的微生物转化。使用反相高效液相色谱法分离并纯化了1的9种微生物代谢产物(2 - 10)。通过包括质谱和核磁共振在内的光谱技术确定了代谢产物的结构。一些微生物代谢产物与用1处理的狗尿液中存在的代谢产物相同。